Bilypsa (Saroglitazar) 4 mg

Indicated for metabolic liver disorders:

• liver Non-Alcoholic Steatohepatitis (NASH): Liver inflammation and damage caused by a buildup of fat.
• 🩸 Non-Alcoholic Fatty Liver Disease (NAFLD): Particularly in patients with comorbidities like Type 2 Diabetes Mellitus or Dyslipidemia (high triglycerides).

Packaging: 4 mg Tablets (Pack of 45).

⚠️ ADMINISTRATION:

• 💊 Dosage: Standard dose is one tablet (4 mg) once daily.
• 🕒 Timing: Can be taken with or without food. Swallow whole with water.
• 📅 Duration: Long-term therapy is often required for liver regeneration; follow the physician's prescription.

• Pregnancy and breastfeeding (safety not established).
• Hypersensitivity to Saroglitazar or any excipients.
• Severe renal or hepatic impairment (requires medical supervision).

Generally well-tolerated, but side effects may include:

• 🤕 General: Asthenia (weakness), Pyrexia (mild fever).
• 🤢 Gastrointestinal: Gastritis, dyspepsia, abdominal discomfort.
• 🤧 Respiratory: Nasopharyngitis.